Is ZBH.SW stock a buy after this intraday drop?

Short term, ZBH.SW stock shows bounce potential due to RSI 18.81. For longer holds, consider Meyka AI’s 12‑month projection (CHF56.70) and company fundamentals. Use tight stops and confirm earnings on 2026‑02‑10 before adding size.

What are realistic targets for ZBH.SW stock in a bounce trade?

Realistic targets: an initial tactical bounce to **CHF75.00** (+11.11%), a medium reversion to the 50‑day average **CHF78.58**, and a longer reversion to the 200‑day **CHF87.90** (+30.22%). Adjust targets to liquidity and risk tolerance.

How do fundamentals affect the ZBH.SW stock bounce thesis?

Fundamentals moderate the trade: EPS **CHF3.19**, PE **21.16**, free cash flow yield **7.63%**. These support value, but net debt to EBITDA near **2.87** and recent EPS decline increase downside risk if earnings disappoint.

How should traders manage risk with ZBH.SW stock now?

Manage risk with small position sizes, limit orders and a stop near **CHF65.00**. Low average volume (**3.00**) increases slippage. Monitor earnings on **2026‑02‑10** and sector moves for confirmation before scaling.

CH Stocks

CHF67.50 intraday drop: ZBH.SW Zimmer Biomet (SIX) oversold bounce setup 30 Jan 2026

ByHuzaifa Zahoor January 30, 2026January 30, 2026

The ZBH.SW stock is trading at CHF67.50 intraday after a CHF3.00 fall (-4.26%), creating a clear oversold setup. Short-term indicators show an RSI of 18.81 and strong ADX at 53.75, which often precede a bounce. We present concise technical triggers, valuation context and a trade plan for traders watching Zimmer Biomet Holdings, Inc. on the SIX. This piece uses data from the exchange and Meyka AI-powered market analysis platform to frame risk and potential targets.